MediPharm Labs (TSXV:LABS)
- Ticker 2:OTC:MEDIF
- CEO:Patrick McCutcheon
MediPharm Labs (TSXV:LABS) Stock Price
MediPharm Labs (TSXV:LABS) Company Overview
Founded in 2015, MediPharm Labs is a B2B Canadian Licensed Producer extracting purified pharma-grade cannabis oil and concentrates for the development of extracts and other cannabis-derived products.
The company, the first to receive a license from the ACMPR to produce oils (without first having to receive a cultivation license), is considered a sector-leader and is likely to be one of the top performers in 2019, as it operates in the fastest growing segment of the market – cannabis-derived CBD oils and extracts.
- Address:151 John Street, Barrie, ON L4N 2L1, Canada
MediPharm Labs (TSXV:LABS) Financials
The latest update from the companyClick Here
Stay updated about
Signup to get updates.
Additionally, McCutcheon holds an Honours Bachelor of Science degree in biology from the University of Western Ontario. He previously worked at Jansen Pharmaceuticals (Johnson & Johnson), where he led the Hospital Division for Renal and Mental Health products.
Strachan is a seasoned entrepreneur, and has continued to apply his leadership to building out MediPharm Labs’ leading-edge facilities, launching operations and growing its workforce. He is also focused on strategically driving business development with the Company’s many supply, contract processing and white label partner LPs.
Chief Financial Officer & Director
He is also a member of the Chartered Accountants of Ontario, and holds a Bachelor of Business Administration from the Schulich School of Business at York University.